Journal of the Peripheral Nervous System

Article	Citations
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	168
Guillain‐Barré syndrome during SARS‐CoV‐2 pandemic: A case report and review of recent literature	147
Guillain‐Barré syndrome associated with SARS‐CoV‐2 infection: A systematic review and individual participant data meta‐analysis	44
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	44
KIF1A‐related disorders in children: A wide spectrum of central and peripheral nervous system involvement	39
Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy	37
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials	31
The neuropathy in hereditary transthyretin amyloidosis: A narrative review	29
Platinum accumulation in oxaliplatin‐induced peripheral neuropathy	27
Oxaliplatin‐ and docetaxel‐induced polyneuropathy: clinical and neurophysiological characteristics	26
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients	21
Peripheral neuropathy symptoms in wild type transthyretin amyloidosis	21
Perisynaptic Schwann cells phagocytose nerve terminal debris in a mouse model of Guillain‐Barré syndrome	20
Small and large fiber sensory polyneuropathy in type 2 diabetes: Influence of diagnostic criteria on neuropathy subtypes	19
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: Neurological and cardiological features	18
Guillain‐Barré syndrome decreases in Singapore during the COVID‐19 pandemic	17
Pathological, ultrasonographic, and electrophysiological characterization of clinically diagnosed cases of pure neuritic leprosy	17
A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease	16
Loss of function MPZ mutation causes milder CMT1B neuropathy	15
Acute and chronic inflammatory neuropathies and COVID‐19 vaccines: Practical recommendations from the task force of the Italian Peripheral Nervous System Association (ASNP)	15
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database	15
Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: Clinical characteristics, electrophysiological study, and response to treatment	14
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review	14
Enhancing peripheral nerve regeneration with neurotrophic factors and bioengineered scaffolds: A basic science and clinical perspective	14
Acquired and inherited amyloidosis: Knowledge driving patients' care	12

Home monitoring of maintenance intravenous immunoglobulin therapy in patients with chronic inflammatory neuropathy	12
Diabetic polyneuropathy: Bridging the translational gap	12
An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM	12
Cold intolerance and neuropathic pain after peripheral nerve injury in upper extremity	12
Report of a fulminant anti‐pan‐neurofascin‐associated neuropathy responsive to rituximab and bortezomib	11
Cutaneous and muscular afferents from the foot and sensory fusion processing: Physiology and pathology in neuropathies	11
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study	11
Antecedent infections inGuillain‐Barrésyndrome patients from south India	11
Neurolymphomatosis, a rare manifestation of peripheral nerve involvement in lymphomas: Suggestive features and diagnostic challenges	10
Incidence and mortality rates of Guillain‐Barré syndrome in Serbia	10
The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases	10
Associations of Guillain‐Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database	9
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ) for identifying pure small fiber neuropathy	9
Acute small fiber neuropathy after Oxford‐AstraZeneca ChAdOx1‐S vaccination: A report of three cases and review of the literature	9
Acute nitrous oxide‐induced neuropathy mimicking Guillain‐Barré syndrome	9
Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathy	9
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies	9
Real world, open label experience with lacosamide against acute painful oxaliplatin‐induced peripheral neurotoxicity	8
Reliability of the Charcot‐Marie‐Tooth functional outcome measure	8
Impact of drug formulations on kinetics and toxicity in a preclinical model of paclitaxel‐induced neuropathy	8
Diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in clinical practice: A survey among Dutch neurologists	8
Sensory neuronopathies: A case series and literature review	7
Charcot–Marie–Toothneuropathies: Current gene therapy advances and the route toward translation	7
Charcot‐Marie‐Tooth disease: Genetic profile of patients from a large Brazilian neuromuscular reference center	7
Clinical features of inherited neuropathy with BSCL2 mutations in Japan	7
From pathogenesis to personalized treatments of neuropathies in hematological malignancies	7
ABSTRACT	7
The Brighton Collaboration case definition: Comparison in a retrospective and prospective cohort of children with Guillain‐Barré syndrome	7
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study	7
Genetic spectrum of MCM3AP and its relationship with phenotype of Charcot‐Marie‐Tooth disease	7
Proximal weakness involvement in the first Italian case of Charcot‐Marie‐Tooth 2CC harboring a novel frameshift variant in NEFH	6
Early onset demyelinating Charcot‐Marie‐Tooth disease caused by a novel in‐frame isoleucine deletion in peripheral myelin protein 2	6
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	6
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS)	5
Diagnosis of Guillain‐Barré syndrome and validation of the Brighton criteria in Malaysia	5
Focal chronic inflammatory demyelinating polyradiculoneuropathy: Onset, course, and distinct features	5
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal	5
A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?	5
Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin‐induced peripheral neurotoxicity	5
Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands	5
Validation of the Italian version of the Charcot‐Marie‐Tooth disease Pediatric Scale	5
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome	5
Comorbidities, anthropometric, demographic, and lifestyle risk factors for ulnar neuropathy at the elbow: A case control study	5
Comparing neuropathy in multiple myeloma and AL amyloidosis	5
Riveting hammer vibration damages mechanosensory nerve endings	5
Vitamin B6 levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	5
The epidemiology of Guillain‐Barré syndrome in Thailand over 13 years (2005‐2017): A nationwide population‐based retrospective cohort study	4
Severe distinct dysautonomia in RFC1‐related disease associated with Parkinsonism	4
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	4
A novel HSPB1 mutation associated with a late onset CMT2 phenotype: Case presentation and systematic review of the literature	4

An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	4
Vibratory testing with the 64 Hz Rydel‐Seiffer tuning fork and its relation to the sural nerve action potential	4
2021 Peripheral Nerve Society virtual event	4
Expanding the spectrum of SPTLC1‐related disorders beyond hereditary sensory and autonomic neuropathies: A novel case of the distinct “S331 syndrome”	4
Expanding the phenotypic spectrum of TRIM2‐associated Charcot‐Marie‐Tooth disease	4
Neutrophil‐lymphocyte ratio in Guillain‐Barré syndrome: A prognostic biomarker of severe disease and mechanical ventilation in Bangladesh	4
SARM1 knockout does not rescue neuromuscular phenotypes in a Charcot‐Marie‐Tooth disease Type 1A mouse model	4
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN1	4
Wearables, sensors, and smart devices for the detection and monitoring of chemotherapy‐induced peripheral neurotoxicity: Systematic review and directions for future research	4
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria	4
Clinical and serological prognostic factors in childhood Guillain‐Barré syndrome: A prospective cohort study in Bangladesh	3
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study	3
Utility of stimulus induced after discharges in the evaluation of peripheral nerve hyperexcitability: Old wine in a new bottle?	3
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	3
Long‐term walking ability and patient satisfaction after lower limb functional surgery in patients affected by Charcot‐Marie‐Tooth disease: A retrospective study	3
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy	3
A recurrent MORC2 mutation causes Charcot‐Marie‐Tooth disease type 2Z	3
Convergent pathological and ultrasound features in hereditary syndromic and non‐syndromic minifascicular neuropathy related to DHH	3
Techniques for the standard histological and ultrastructural assessment of nerve biopsies	3
Anxiety and depression in small fiber neuropathy	3
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	3
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves	3
Relation of exercise and pain in patients with idiopathic distal axonal polyneuropathies	3
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	3
An approach to assessing immunoglobulin dependence in chronic inflammatory demyelinating inflammatory polyneuropathy	3
Validation of the Italian version of the Charcot‐Marie‐Tooth Health Index	3
Co‐expression gene modules involved in cisplatin‐induced peripheral neuropathy according to sensitivity, status, and severity	3
Liver‐directed drugs for transthyretin‐mediated amyloidosis	3
2020 Peripheral Nerve Society Virtual Event	3
Validation of a new hand function outcome measure in individuals with Charcot‐Marie‐Tooth disease	3
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review	3
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A1	2
Clinical scoring systems for the risk of cardiovascular autonomic neuropathy in type 1 and type 2 diabetes: A simple tool	2
Nerve biopsy in acquired neuropathies	2
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods	2
A prospective study on surgical management of foot deformities in Charcot Marie tooth disease	2
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO)	2
	2
Autoimmune nodo‐paranodopathies 10 years later: Clinical features, pathophysiology and treatment	2
Abstracts	2
Validation of the Italian version of the pediatric CMT quality of life outcome measure	2
HINT1‐related neuropathy in Greek patients with Charcot‐Marie‐Tooth disease	2
Abstracts of the Eleventh Annual Meeting of the Associazione Italiana Sistema Nervoso Periferico (ASNP)	2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy	2
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy	2
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome	2
Unusual upper limb features in SORD neuropathy	2
	2
Incidence of Guillain‐Barré syndrome in an Uruguayan population. A prospective cohort study	2
Translating diabetic peripheral neuropathy	2
The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain‐Barré syndrome	2
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	2
GJB1 variants in Charcot‐Marie‐Tooth disease X‐linked type 1 in Mali	2
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	2
No evidence of improvement in neuropathy after renal transplantation in patients with end stage kidney disease	2
Electrodiagnostic subtyping in Guillain‐Barré syndrome: Use of criteria in practice based on a survey study in IGOS	2
Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy	2
Chronic inflammatory demyelinating polyneuropathy with hypertrophic nerves	1
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex	1
Inter‐rater reliability of the Rasch‐modified medical research council scoring criteria for manual muscle testing in neuromuscular diseases	1
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years	1
Normal structure and pathological features in peripheral neuropathies	1
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	1
Ophthalmological involvement in wild‐type transthyretin amyloidosis: A multimodal imaging study	1
A novel homozygous variant extending the peripheral myelin protein 22 by 9 amino acids causes early‐onset Charcot‐Marie‐Tooth disease with predominant severe sensory ataxia	1
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	1
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome	1
Validation of the parent‐proxy pediatric Charcot‐Marie‐Tooth disease quality of life outcome measure	1
The autoimmune vulnerability of the node of Ranvier	1
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	1
Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro	1
Evidence for spontaneous regulation of the humoral IgM anti‐GM1 autoimmune response by IgG antibodies in multifocal motor neuropathy patients	1
Assessing diabetic polyneuropathy in Spanish‐speaking patients: Translation and validation of the Toronto Clinical Neuropathy Score	1
Two new mouse models of Gjb1‐associated Charcot–Marie–Tooth disease type 1X	1
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	1
	1
The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy	1
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation	1
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report	1
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor	1

Sural nerve biopsy utility by masked assessment of individual histologic preparations	1
Lessons from late onset Charcot‐Marie‐Tooth disease	1
Phase 2a randomized controlled study investigating the safety and efficacy of PDA‐002 in diabetic peripheral neuropathy	1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy	1
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)	1
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	1
Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy	1
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	1
Hereditary neuropathies: A pathological perspective	1
	1
	1
High glucose level as a modifier factor in CMT1A patients	1
	1